Atlas Salt Announces Updated Feasibility Study with Enhanced Results for the Great Atlantic Salt Project; $920M Post-Tax NPV8 and 21.3% Post-Tax IRR

Stock Information for Sirona Biochem Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sirona Biochem Corp.

OTC Markets Group Welcomes ATLAS SALT INC. to OTCQX
Atlas Salt to Begin Trading on OTCQX Under the Symbol "SALQF"
Atlas Salt Signs Strategic MOU with Hatch as Lead Engineering and IPD Partner for the Great Atlantic Salt Project
Atlas Salt Announces Filing of NI 43-101 Technical Report for the Updated Feasibility Study of Its Great Atlantic Salt Project
Atlas Salt Signs Memorandum of Understanding with Continental Conveyor for Material Handling Systems at the Great Atlantic Salt Project
Atlas Salt Announces Closing of Brokered LIFE Private Placement and Participation of Strategic Investor
Atlas Salt Announces Order Book Interest Exceeding Targeted Gross Proceeds of $8,000,000 on LIFE Private Placement
Atlas Salt Announces LIFE Private Placement Targeting Gross Proceeds of up to $8 Million

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.